A flowchart showing how dermatologists treat male-pattern baldness from UpToDate, the industry-standard reference Treatment 3/29/2026
Dermatologists use treatments like oral minoxidil, finasteride, and RU58841 for male-pattern baldness, considering side effects and patient preferences. Photobiomodulation is noted as mildly effective but costly, while PRP is debated for its effectiveness compared to microneedling.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Transitioning from fin to RU58841 + Oral Minoxidil - how long until I lose all my fin gains?
The user transitioned from finasteride to RU58841 and oral minoxidil to maintain hair gains while avoiding systemic DHT suppression. They have not experienced increased shedding or side effects since stopping finasteride and hope RU58841 will preserve their hair.
community Finasteride and Topical Minoxidil to Dutasteride and Oral Minoxidil. Is RU58841 still helping?
The user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil, questioning the effectiveness and safety of continuing RU58841. They experienced hair loss improvement initially but are now considering stopping RU58841 due to cost and safety concerns.
community Seeking Alternatives to Finasteride: Pyrilutamide, RU58841, and Oral Minoxidil
The conversation is about treating hair loss without finasteride or dutasteride due to sensitivity causing gynecomastia. The user plans to use pyrilutamide, RU58841, and oral Minoxidil instead.
community Hair loss still progressing despite finasteride, dutasteride, oral minoxidil, and trying RU58841. What next?
Despite using finasteride, dutasteride, oral minoxidil, and RU58841, hair loss continues to progress. Options considered include increasing dutasteride or minoxidil doses, adding topical treatments, and exploring other potential causes of hair loss.
community 25M, Aggressive Diffuse NW5 – 5 Months Minoxidil + 3 Months Oral Finasteride + RU58841 | Progress or Not?
A 25-year-old with aggressive diffuse NW5 hair loss is using Minoxidil, oral Finasteride, RU58841, Ketoconazole, and dermastamping, experiencing slow progress and mental health struggles. Despite some visible regrowth, the user feels discouraged due to ongoing hair loss and is seeking reassurance and advice.
Related Research
6 / 6 resultsresearch Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction
This review discusses advanced biomedical technologies, such as nanotechnology and stem cell-based approaches, for treating androgenetic alopecia, detailing their benefits, current applications, and challenges, without reporting new experimental results.
research Drug discovery for alopecia: gone today, hair tomorrow
This review discusses current knowledge on the biological mechanisms of different types of alopecia but reports no new clinical findings; the authors highlight future research directions, especially regarding epidermal stem cells and immune pathways.
research A systematic summary of survival and death signalling during the life of hair follicle stem cells
This review examines the life cycle, biomarkers, and functions of hair follicle stem cells, emphasizing their role in hair loss therapy and other skin and hair disorders, but reports no new clinical results.
research Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
This source discusses how radiotherapy-induced skin fibrosis, a chronic side effect affecting cancer survivors' quality of life, is driven by ongoing inflammation and fibroblast activity, and emphasizes the need for comprehensive dermatologic management and better diagnostic tools.
research Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
This review discusses low-level light therapy for androgenetic alopecia and female pattern hair loss, noting minimal clinical evidence on its efficacy and the need for more controlled studies.
research CLINICAL UPDATES IN HAIR
This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.